Wanze's disclosure of the 2022 semi -annual report achieved revenue of 375 million yuan

On July 25, the A -share listed company Wanze (code: 000534.SZ) released the 2022 semi -annual performance report.

From January 1, 2022-June 30, 2022, the company realized operating income of 375 million yuan, an increase of 33.78%year-on-year, and net profit was 74.5423 million yuan, an increase of 16.25%year-on-year, and the basic earnings per share were 0.15 yuan.

The company's industry is biological products.

Among them, the revenue of the pharmaceutical manufacturing industry was 298 million yuan, a year -on -year increase of 17.04%. The industrial revenue of non -ferrous metal smelting and voltage margin was 66.3104 million yuan, an increase of 207.61%year -on -year, and other revenue of 10.3468 million yuan, an increase of 165.71%year -on -year.

During the company's reporting period, the total assets at the end of the period were 2.369 billion yuan, the operating profit was 94.9143 million yuan, the accounts receivable were 208 million yuan, and the net cash flow generated by operating activities was -22.416 million yuan.The cash is 315 million yuan.

Wanze, the company's full name Wanze Industrial Co., Ltd., was established on October 25, 1992. The current general manager Bi Tianxiao, the main business is the research and development, production and sales of micro -ecological live bacteria products, high -temperature alloys and productsEssence

- END -